We will be present at the 32nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2022) in Lisbon from the 23rd to the 26th April 2022.

Come and meet us at the following sessions :

Saturday 23 – 12.00 – 13.00

Luc Deroche: Characterisation of in vivo acquired ceftolozane-tazobactam resistance in Pseudomonas aeruginosa using a PKPD modelling approach

 

Sunday 24 – 12.00 -13.00

Alexia Chauzy – P1337: Comparison between pharmacokinetic-pharmacodynamic modelling results of ceftaroline against methicillin-resistant Staphylococcus aureus after time kill and hollow-fibre experiments.

Alexia Chauzy – P1334 : In vivo pharmacokinetic-pharmacodynamic modelling of Acinetobacter baumannii inoculum effect on polymyxin B in a murine thigh infection model

Mathilde Lacroix – P1343 : In vitro PK/PD modelling of polymyxin B against resistant strain of A. baumannii in presence of mucin

Romain Aubry – Abstract: 03559: Semi-mechanistic PKPD modelling of combined ceftazidime/avibactam and colistin against a multidrug-resistant strain of Klebsiella pneumoniae

Romain Aubry – Abstract: 03484: Systematic interaction screening of ceftazidime/avibactam and colistin against eighteen carbapenem-producing Escherichia coli and Klebsiella pneumoniae strains

Sunday 24 – 13.30 – 15.30

William Couet – Don’t get lost in translation: the use of preclinical PK/PD models in anti-infective drug development: The role of in vivo models

Monday 25 – 12.00 -13.00

Kévin Brunet – Abstract: 03560: PEG-15-hydroxystearate non-ionic surfactant enhances amphotericin B activity against Mucorales in vitro.

 

ISAP Pre-ECCMID meeting (Friday April 22 at 16.15, Porto Salvo)

Young Investigator Oral Session

Mathilde Lacroix  : In vitro PK/PD modelling of polymyxin B against resistant strain of A. baumannii in presence of mucin

Romain Aubry : Semi-mechanistic PKPD modelling of combined ceftazidime/avibactam and colistin against a multidrug-resistant strain of Klebsiella pneumoniae